Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohiro Fukuda

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Plos One|November 7, 2017
The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registryTomohiro Fukuda, Makoto Naganuma, Shinya Sugimoto, et al.
Inflammatory Intestinal Diseases|March 2, 2026
Effectiveness of Intravenous Corticosteroid in Patients with Ulcerative Colitis after Oral Corticosteroid Failure: Differences by Prior Response to Oral Therapy in a Multicenter Cohort StudyTomohiro Fukuda, Kenji Tatsumi, Naoko Inagaki, et al.
Alimentary Pharmacology & Therapeutics|February 26, 2022
Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitisShintaro Sagami, Taku Kobayashi, Kanako Aihara, et al.
Inflammatory Bowel Diseases|September 29, 2018
Efficacy of Therapeutic Intervention for Patients With an Ulcerative Colitis Mayo Endoscopic Score of 1Tomohiro Fukuda, Makoto Naganuma, Shinya Sugimoto, et al.
Healthcare (Basel, Switzerland)|July 2, 2021
A Case of Crohn's Disease with Cardiac Tamponade Caused by Tuberculous Pericarditis: Assessment of a Rare PhenomenonKeiichi Tominaga, Takanao Tanaka, Mimari Kanazawa, et al.
Intestinal Research|February 5, 2020
5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitisShinta Mizuno, Keiko Ono, Yohei Mikami, et al.
Journal of Gastroenterology|May 19, 2019
Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide surveyMakoto Naganuma, Shinya Sugimoto, Hideo Suzuki, et al.
Digestion|June 26, 2019
Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative ColitisYusuke Yoshimatsu, Makoto Naganuma, Shinya Sugimoto, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2022
Lower effectiveness of intravenous steroid treatment for moderate-to-severe ulcerative colitis in hospitalised patients with older onset: a multicentre cohort studyShinji Okabayashi, Hajime Yamazaki, Keiichi Tominaga, et al.
Journal of Gastroenterology and Hepatology|April 7, 2020
Mucosal concentrations of N-acetyl-5-aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamineTomohiro Fukuda, Makoto Naganuma, Kaoru Takabayashi, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Plos One|November 7, 2017
The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registryTomohiro Fukuda, Makoto Naganuma, Shinya Sugimoto, et al.
Inflammatory Intestinal Diseases|March 2, 2026
Effectiveness of Intravenous Corticosteroid in Patients with Ulcerative Colitis after Oral Corticosteroid Failure: Differences by Prior Response to Oral Therapy in a Multicenter Cohort StudyTomohiro Fukuda, Kenji Tatsumi, Naoko Inagaki, et al.
Alimentary Pharmacology & Therapeutics|February 26, 2022
Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitisShintaro Sagami, Taku Kobayashi, Kanako Aihara, et al.
Inflammatory Bowel Diseases|September 29, 2018
Efficacy of Therapeutic Intervention for Patients With an Ulcerative Colitis Mayo Endoscopic Score of 1Tomohiro Fukuda, Makoto Naganuma, Shinya Sugimoto, et al.
Healthcare (Basel, Switzerland)|July 2, 2021
A Case of Crohn's Disease with Cardiac Tamponade Caused by Tuberculous Pericarditis: Assessment of a Rare PhenomenonKeiichi Tominaga, Takanao Tanaka, Mimari Kanazawa, et al.
Intestinal Research|February 5, 2020
5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitisShinta Mizuno, Keiko Ono, Yohei Mikami, et al.
Journal of Gastroenterology|May 19, 2019
Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide surveyMakoto Naganuma, Shinya Sugimoto, Hideo Suzuki, et al.
Digestion|June 26, 2019
Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative ColitisYusuke Yoshimatsu, Makoto Naganuma, Shinya Sugimoto, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2022
Lower effectiveness of intravenous steroid treatment for moderate-to-severe ulcerative colitis in hospitalised patients with older onset: a multicentre cohort studyShinji Okabayashi, Hajime Yamazaki, Keiichi Tominaga, et al.
Journal of Gastroenterology and Hepatology|April 7, 2020
Mucosal concentrations of N-acetyl-5-aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamineTomohiro Fukuda, Makoto Naganuma, Kaoru Takabayashi, et al.
Pageof 4